Adefovir

Drug Profile

Adefovir

Alternative Names: GS 0393; GS 393; Phosphonylmethoxyethyl-a; PMEA

Latest Information Update: 21 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Academy of Sciences of the Czech Republic; Nonindustrial source; Rega Institute for Medical Research
  • Developer Academy of Sciences of the Czech Republic; Gilead Sciences; Nonindustrial source
  • Class Adenine nucleotides; Antiretrovirals; Phosphonic acids; Purine nucleotides; Small molecules
  • Mechanism of Action Cell differentiation stimulants; DNA-directed DNA polymerase inhibitors; Immunomodulators; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Graft-versus-host disease; Hepatitis B; HIV infections; Rheumatic disorders

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 08 May 2000 Discontinued-II for HIV infections treatment in USA (IV)
  • 08 May 2000 Discontinued-Preclinical for Hepatitis B in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top